Komori
Nihon Trim (6788) · TargetRestated

Building New Business Pillars Beyond Household Water Ionizers

First written in FY2016. 8 of 16 entries say "Restated". Latest entry: FY2025.

16entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2019-Q3AdvancedFY2022-Q3 – FY2023-Q3RestatedFY2023 – FY20252016: 320162017: 420172018: 120182019: 120192020: 120202021: 220212022: 120222023: 220232024: 020242025: 12025
Same theme, other companies
Diversifying Revenue Sources Through New BusinessesA theme 163 companies write about · 0 as a headwind · 168 as a tailwind

28 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 163 companies compared. The sentences above are computed from all 163.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「Our group’s businesses comprise the water healthcare business and the medical-related business. The water healthcare business currently accounts for 87.1% of consolidated net sales, but going forward we aim to establish the medical-related business as one of our new business pillars.」

    The company reaffirmed its policy of expanding the medical-related business as a new business pillar while maintaining the water healthcare business as its foundation.
  2. FY2023RestatedAnnual report

    「Our group’s businesses comprise the water healthcare business and the medical-related business. The water healthcare business currently accounts for 87.3% of consolidated net sales, but going forward we aim to establish the medical-related business as one of our new business pillars.」

    The company reaffirmed its policy of establishing the medical-related business as a new business pillar while maintaining the water healthcare business as its foundation.
  3. FY2023-Q3AdvancedAnnual report

    「We are also actively promoting new businesses for launch in the next fiscal year, including services for storage customers using products generated during the culturing of cord blood and umbilical cords, such as exosomes, and femtech businesses providing comprehensive support for women’s health in partnership with major operating companies.」

    For new business pillars, the company is preparing businesses using products generated through cord blood and umbilical cord culturing, as well as femtech businesses focused on women’s health, for launch in the next fiscal year.
  4. FY2022-Q3AdvancedAnnual report

    「While growing our existing cell banking business, we will use the company’s network to consider developing businesses in data science, including preventive medicine, using new technologies such as AI, and developing new products using stem cells, including through M&A.」

    The company has specified new medical-related business pillars, including AI-based data science (preventive medicine), new products using stem cells and expansion involving M&A.
  5. FY2021RestatedAnnual report

    「We believe that, for our group to achieve sustainable growth, it is necessary to build new business pillars in addition to our current core water-ionizer-related business. Medical-related businesses are our primary focus, but we are also working to create new businesses using electrolyzed hydrogen water in the agriculture and industrial sectors, all of which we believe have significant future potential.」

    The company reaffirmed its policy of building new business pillars outside its water-ionizer-related business, centered on medical care and extending into agriculture and industry.
  6. FY2021-Q3AdvancedAnnual report

    「In addition, we are expanding our business with a view to investments in Cuorips Inc. mentioned above, the capital and business alliance with 株式会社グレイスグループ, other cell storage businesses, cell-based pharmaceutical development and global expansion.」

    In addition to existing medical-related businesses, the company indicated efforts to expand into other cell storage businesses, cell-based pharmaceutical development and global operations.
  7. FY2020RaisedAnnual report

    「One such business is our medical-related business, including electrolysis-water dialysis, cord blood banking and hospital operations in China. In addition, we are working to create new businesses using electrolyzed hydrogen water in the agriculture and industrial sectors, all of which we believe have significant future potential.」

    In addition to medical-related businesses, the company explicitly identified the industrial sector as a target for creating new businesses, broadening the scope of its new business pillars.
  8. FY2019-Q3RestatedAnnual report

    「While further expanding our current core water healthcare business, we will significantly grow our medical-related business, which has entered a growth phase, as a new business pillar and transition into a medical company. We will also actively pursue overseas expansion and M&A with a view to future sustainable growth.」

    The company reaffirmed its policy of expanding the water healthcare business, growing the medical-related business as a new business pillar, and pursuing overseas expansion and M&A opportunities.
  9. FY2018-Q3RestatedAnnual report

    「To achieve sustainable growth in the future, our group will actively expand the water-ionizer sales business and businesses in the medical and agriculture sectors, as well as overseas operations centered on Asia and new fields such as advanced medical services, with M&A also in mind, with the aim of evolving into a global medical company group.」

    The company reaffirmed its policy of continuing to develop new businesses based on water ionizers, including medical care, agriculture, overseas expansion centered on Asia and M&A opportunities.
  10. FY2018-Q2RestatedAnnual report

    「To achieve sustainable growth in the future, the Group will actively expand overseas, particularly in Asia, and enter new business fields, including advanced medicine, while considering M&A, in addition to expanding its water ionizer sales business and its healthcare and agriculture businesses, thereby advancing to a global medical business group.」

    The company reaffirmed its policy of continuing new businesses outside household water ionizers, including medical care, agriculture, advanced medical services, overseas expansion centered on Asia and M&A opportunities.
  11. FY2018-Q1RestatedAnnual report

    「To achieve sustainable growth in the future, our group is actively pursuing expansion into new business fields, including the water-ionizer sales business, expansion in the medical and agriculture sectors, overseas expansion centered on Asia, and advanced medical services, with M&A also in mind.」

    The company reaffirmed its policy of continuing to develop new businesses based on water ionizers, including medical care, agriculture, overseas expansion in Asia and M&A opportunities.
  12. FY2017RaisedAnnual report

    「To achieve this, we are actively entering new businesses and expanding our operations, including electrolysis-water dialysis in the medical field, reduced-chemical vegetables in agriculture, cord blood bank operations and the development of domestically produced cell-based pharmaceuticals in regenerative medicine, and the operation of hospitals for chronic diseases in China.」

    In addition to the existing medical, agriculture, cord blood and China hospital businesses, the company explicitly identified domestically produced cell-based pharmaceutical development as a new business pillar, broadening its target fields.
  13. FY2017-Q3The wording has been strengthened from considering these opportunities to pursuing specific initiatives.Annual report

    「We are also pursuing specific initiatives involving overseas expansion and M&A in the field of advanced medical services.」

    The wording regarding overseas expansion and M&A changed from “considering these opportunities” to “pursuing specific initiatives,” but no individual transaction or completed action has been disclosed.
  14. FY2017-Q2RestatedAnnual report

    「To achieve sustainable growth in the future, our group will focus not only on expanding the water-ionizer sales business, but also on developing businesses in new fields such as agriculture and medical care and expanding advanced medical services, with the aim of evolving from a household medical-device manufacturer into a medical company. We are also actively pursuing entry into new business fields with overseas expansion and M&A in mind.」

    The company reaffirmed its policy of continuing to enter new businesses in agriculture, medical care and advanced medical services, with overseas expansion and M&A in mind.
  15. FY2017-Q1RaisedAnnual report

    「To achieve sustainable growth in the future, our group will accelerate the expansion of the water-ionizer sales business and new fields such as agriculture and medical care, while also focusing on expanding advanced medical services, with the aim of evolving from a household medical-device manufacturer into a medical company. We are also actively pursuing entry into new business fields with overseas expansion and M&A in mind.」

    In addition to expanding existing new businesses such as medical care and agriculture, the company has broadened its scope to include entering new businesses with overseas expansion and M&A in mind.
  16. FY2016First statedAnnual report

    「We believe that, for our group to achieve sustainable growth, it is necessary to build new business pillars in addition to our current core household water-ionizer business. To achieve this, we are actively entering new businesses and expanding our operations, including electrolysis-water dialysis in the medical field, reduced-chemical vegetables in agriculture, cord blood bank operations in regenerative medicine, and the operation of hospitals for chronic diseases in China.」

    The company identified medical care, agriculture, regenerative medicine and hospital operations in China as business pillars following its household water-ionizer business.
Moved together

"Clarification of the functions of electrolyzed hydrogen water and differentiation from other types of water" moved the same way as this thread, in the same document, in 5 of its 16 moves.

555444★123456
  1. ★This thread
  2. 1Clarification of the functions of electrolyzed hydrogen water and differentiation from other types of water5×
  3. 2Storage, research and provision to medical institutions of cord blood-derived stem cells5×
  4. 3Expansion of cord blood bank storage capacity5×
  5. 4Full-scale rollout of the electrolysis water dialysis system4×
  6. 5Clinical Evidence for Electrolyzed Water Hemodialysis and Raising Awareness4×
  7. 6Strengthening Sales Capabilities and Improving Sales Efficiency4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nihon Trim yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.